These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 35597366

  • 1. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
    Nayeem MA, Hanif A, Geldenhuys WJ, Agba S.
    Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
    [Abstract] [Full Text] [Related]

  • 2. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
    Nayeem MA, Geldenhuys WJ, Hanif A.
    Adv Pharmacol; 2023 Dec; 97():37-131. PubMed ID: 37236764
    [Abstract] [Full Text] [Related]

  • 3. Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A2A receptor and plasma oxylipins.
    Hanif A, Edin ML, Zeldin DC, Morisseau C, Falck JR, Ledent C, Tilley SL, Nayeem MA.
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():83-95. PubMed ID: 28890385
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ.
    Hanif A, Edin ML, Zeldin DC, Morisseau C, Nayeem MA.
    Am J Physiol Regul Integr Comp Physiol; 2016 Oct 01; 311(4):R676-R688. PubMed ID: 27488890
    [Abstract] [Full Text] [Related]

  • 8. Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.
    Hanif A, Edin ML, Zeldin DC, Morisseau C, Nayeem MA.
    PLoS One; 2016 Oct 01; 11(9):e0162147. PubMed ID: 27583776
    [Abstract] [Full Text] [Related]

  • 9. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X, Zhang XA, Wang DW.
    Adv Drug Deliv Rev; 2011 Jul 18; 63(8):597-609. PubMed ID: 21477627
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels.
    Yadav VR, Hong KL, Zeldin DC, Nayeem MA.
    Mol Cell Biochem; 2016 Nov 18; 422(1-2):197-206. PubMed ID: 27629787
    [Abstract] [Full Text] [Related]

  • 11. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
    Marowsky A, Meyer I, Erismann-Ebner K, Pellegrini G, Mule N, Arand M.
    Arch Toxicol; 2017 Nov 18; 91(11):3571-3585. PubMed ID: 28975360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adenosine A2A receptor and vascular response: role of soluble epoxide hydrolase, adenosine A1 receptor and angiotensin-II.
    Hanif A, Agba SO, Ledent C, Tilley SL, Morisseau C, Nayeem MA.
    Mol Cell Biochem; 2021 May 18; 476(5):1965-1978. PubMed ID: 33511551
    [Abstract] [Full Text] [Related]

  • 14. CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators.
    Shi Z, He Z, Wang DW.
    Molecules; 2022 Jun 16; 27(12):. PubMed ID: 35744996
    [Abstract] [Full Text] [Related]

  • 15. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
    Zhu Y, Blum M, Hoff U, Wesser T, Fechner M, Westphal C, Gürgen D, Catar RA, Philippe A, Wu K, Bubalo G, Rothe M, Weldon SM, Dragun D, Schunck WH.
    PLoS One; 2016 Jun 16; 11(1):e0145645. PubMed ID: 26727266
    [Abstract] [Full Text] [Related]

  • 16. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE, Elshenawy OH, Abdelrady M, El-Kadi AO.
    Toxicol Lett; 2014 Apr 07; 226(1):53-62. PubMed ID: 24472606
    [Abstract] [Full Text] [Related]

  • 17. Role of oxylipins in cardiovascular diseases.
    Nayeem MA.
    Acta Pharmacol Sin; 2018 Jul 07; 39(7):1142-1154. PubMed ID: 29877318
    [Abstract] [Full Text] [Related]

  • 18. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.
    Edin ML, Wang Z, Bradbury JA, Graves JP, Lih FB, DeGraff LM, Foley JF, Torphy R, Ronnekleiv OK, Tomer KB, Lee CR, Zeldin DC.
    FASEB J; 2011 Oct 07; 25(10):3436-47. PubMed ID: 21697548
    [Abstract] [Full Text] [Related]

  • 19. Intimal smooth muscle cells are a source but not a sensor of anti-inflammatory CYP450 derived oxylipins.
    Thomson S, Edin ML, Lih FB, Davies M, Yaqoob MM, Hammock BD, Gilroy D, Zeldin DC, Bishop-Bailey D.
    Biochem Biophys Res Commun; 2015 Aug 07; 463(4):774-80. PubMed ID: 26086108
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
    Theken KN, Schuck RN, Edin ML, Tran B, Ellis K, Bass A, Lih FB, Tomer KB, Poloyac SM, Wu MC, Hinderliter AL, Zeldin DC, Stouffer GA, Lee CR.
    Atherosclerosis; 2012 Jun 07; 222(2):530-6. PubMed ID: 22503544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.